Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRAPPC6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDCD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECHDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHX29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIDO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST8SIA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
AGMAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BZW1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOCS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ROCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on